US 6,146,624 AGranted

Human ubiquitin-conjugating enzymes

AssigneeIncyte Pharmaceuticals, Inc.

InventorsPreeti Lal, Jennifer L. Hillman, Neil C. Corley

Life of this patent

Estimating the term…

Abstract

The invention provides a human ubiquitin-conjugating enzyme (HUBI) and polynucleotides which identify and encode HUBI. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of HUBI.

Claims4

Dependent claims

A substantially purified human vesicle trafficking protein (HUBI) comprising an amino acid sequence selected from the group consisting of SEQ ID NO:1 and SEQ ID NO:3.

Dependencies are inferred from the claim text.

Facts

Application: 09/359,967Filed 22 Jul 1999 · division
Priority: 23 Sep 1997
Granted: 14 Nov 2000
Term ends: Not estimatedThe source records don’t support an estimate.

Classification9 codes

C12N 9/93
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes: ligases
A61P 25/28
Drugs for disorders of the nervous system: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents,…
A61P 35/00
Antineoplastic agents
C07K 14/4702
Not used: regulators; Modulating activity

Family

Serial933,750Parent of this continuation-in-part · filed 23 Sep 1997
Serial965,689Parent of this division · filed 6 Nov 1997
US 6,015,702 AParent of this division
US 5,932,442 AParent of this continuation-in-part
US 6,146,624 AThis patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results